This is a retrospective study covering the period 2022-2023 on urine samples received at the bacteriology-virology laboratory of the CHNU of FANN. The aim was to determine the prevalence and sensitivity profile of ESBL-producing strains of Klebsiella spp to other antibiotic molecules. A total of 549 urine samples were positive for a bacterium, of which 113 (20.58%) were attributable to Klebsiella spp., with a predominance of Klebsiella pneumoniae n=90 (79.65%). 59.26% were producers of extended-spectrum betalactamase (ESBL), of which 56.25% (n=27/48) were of hospital origin. Good sensitivity was noted to imipenem (78.40%) and amikacin (70.59%).
No takes yet. Share an insight, caveat, or question.
Sene et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: